Carcinogenesis Advance Access published online on January 3, 2008
Carcinogenesis, doi:10.1093/carcin/bgm245
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grb2 Binding to Tyr284 in TβR-II is Essential for Mammary Tumor Growth and Metastasis Stimulated by TGF-β
Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80045
Corresponding Author: William P. Schiemann, Department of Pharmacology, University of Colorado Health Sciences Center, RC1 South Tower, Room L18-6110, 12801 East 17th Avenue, PO Box 6511, Aurora, Colorado 80045. Phone: (303)724-1541. Fax: (303)724-3663. E-mail: Bill.Schiemann{at}uchsc.edu
We demonstrated previously that growth factor receptor bound protein 2 (Grb2) associates with the TGF-β type II receptor (TβR-II) upon its phosphorylation on Tyr284 by Src. Although this phosphotransferase reaction is critical in mediating TGF-β stimulation of epithelial-mesenchymal transition (EMT) and invasion in mammary epithelial cells (MECs), the necessity of Grb2 in promoting these TGF-β-dependent events remains purely correlative. Herein we further evaluated the role of Grb2 in mediating the oncogenic activities of TGF-β and show that the binding of Grb2 to TβR-II paralleled the induction of EMT in MECs stimulated by TGF-β. Introducing siRNAs against Grb2 or expression of a TβR-II mutant that cannot bind Grb2 (i.e., Y284F-TβR-II) had no effect on the ability of TGF-β to activate Smad3, but significantly impaired its stimulation of p38 MAPK in MECs. Importantly, these same cellular conditions also prevented the ability of MECs to undergo EMT in response to TGF-β, and to invade synthetic basement membranes when stimulated by β3 integrin and TGF-β. Finally, we show that the ability of TGF-β to stimulate breast cancer growth and pulmonary metastasis in mice required TβR-II to be phosphorylated on Tyr284, which activated p38 MAPK in developing and progressing mammary tumors. Collectively, our findings have established the necessity of Grb2 in mediating TGF-β stimulation of EMT and invasion in MECs, as well as demonstrated the essential function of the 
vβ3 integrin:Src:phospho-Y284-TβR-II:Grb2:p38 MAPK signaling axis to promote breast cancer growth and metastasis in vivo.
Key Words: EMT • Grb2 • p38 MAPK • Pulmonary Metastasis • TGF-β
Received August 18, 2007; revised October 24, 2007; accepted October 26, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Tiedemann, O. Hussein, G. Sadvakassova, Y. Guo, P. M. Siegel, and S. V. Komarova Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-{beta}/MAPK Signaling Pathways J. Biol. Chem., November 27, 2009; 284(48): 33662 - 33670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Moustakas and C.-H. Heldin The regulation of TGF{beta} signal transduction Development, November 15, 2009; 136(22): 3699 - 3714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Lee, A. R. Albig, M. Regner, B. J. Schiemann, and W. P. Schiemann Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-{beta} in mammary epithelial cells via a MMP-dependent mechanism Carcinogenesis, December 1, 2008; 29(12): 2243 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Neil, K. M. Johnson, R. A. Nemenoff, and W. P. Schiemann Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-{beta} through a PGE2-dependent mechanisms Carcinogenesis, November 1, 2008; 29(11): 2227 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ding, C. L. Gladson, H. Wu, H. Hayasaka, and M. A. Olman Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner J. Biol. Chem., October 3, 2008; 283(40): 26839 - 26849. [Abstract] [Full Text] [PDF]
|
|